Hunan Corun New Energy and Shareholder Probed Over Disclosure Violations
The company says it and its controlling shareholder are being probed by a securities regulator over suspected information-disclosure violations.
Related stories
FDA Grants Tentative Approval for Dr. Reddy’s Lenacapavir
The U.S. FDA granted tentative approval for Dr. Reddy’s twice-yearly injectable lenacapavir.
M impact | REGULATION | Nov 02, 2026, 02:15 PM UTC
South Korea Financial Authorities to Tighten Rules on Bank Chair Third Terms
South Korea’s financial authorities plan to raise the bar for financial holding company chairs seeking a third consecutive term.
L impact | REGULATION | Nov 02, 2026, 02:12 PM UTC
Inovio Presents Accelerated FDA Approval of VOCERYQ
Inovio presents accelerated FDA approval of VOCERYQ for adults with RRP.
M impact | REGULATION | Nov 02, 2026, 02:10 PM UTC
India Pollution Board Imposes 3.9 Million Rupee Compensation on Tube Investments
L impact | REGULATION | Nov 02, 2026, 01:58 PM UTC
Hangzhou SDIC Microelectronics and Controlling Shareholder Probed by Regulator
The company says it and its controlling shareholder are under investigation over suspected information disclosure violations.
L impact | REGULATION | Nov 02, 2026, 01:41 PM UTC
FDA Places Bright Minds Biosciences Seizure Drug Application on Partial Hold
Bright Minds Biosciences said the FDA placed its drug application and planned trial for a seizure treatment on partial clinical hold following a review. The stock fell 36% to $35 i
M impact | REGULATION | Nov 02, 2026, 01:19 PM UTC